PT-141 Has FDA Approval for This — What the Research-Grade Version Actually Costs
Bremelanotide is the rare compound on this blog with real FDA approval for a female-specific indication. Here's what's actually approved, what's sold differently as "PT-141," and the real 119% price spread between suppliers.
PT-141 is unusual among the compounds covered on this blog: it's not a promising mechanism or an extrapolation from animal research. The FDA approved it, under its branded name, specifically for a female sexual-health indication.
What's Actually FDA-Approved
On June 21, 2019, the FDA approved Vyleesi (bremelanotide injection) for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women — "acquired" meaning the low desire developed after a period of normal function, "generalized" meaning it isn't limited to one partner or situation. The approval rested on two identical 24-week randomized, double-blind, placebo-controlled trials covering 1,247 premenopausal women aged 19 to 56. The approved product is a prefilled autoinjector, self-administered at least 45 minutes before anticipated activity.
What's Sold as "PT-141" Elsewhere
This is the distinction worth being clear-eyed about: what's sold as "PT-141" on research-compound sites, including on this one, is not the Vyleesi product — not the same formulation, not administered through the studied autoinjector protocol, and not manufactured under the same regulatory oversight. It's the same underlying molecule, bremelanotide, sold as a research compound rather than as the approved prescription drug. That's not a claim that one is fake and the other real — it's that they're genuinely different products with different quality control, and worth knowing which one you're actually looking at before deciding anything.
What It Actually Costs
Across the four suppliers we currently track carrying PT-141 at 10mg, prices range from £19.99 to £43.75 — a spread of roughly 119% between the cheapest and most expensive listing for the identical product. That gap is worth checking before buying regardless of which path you're considering.
What This Means Practically
If HSDD is the actual concern, the approved, studied, doctor-prescribed path is Vyleesi — a real conversation to have with a doctor, not something this site sells or substitutes for. If you're specifically researching the compound as sold on research-use sites, know you're looking at a different product from the approved one, and the same rule applies as everywhere else on this blog: check what you'd actually be buying and from whom before you buy it.